XML 75 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue from Contracts with Customers - Summary of Disaggregation of Revenues by Major Revenue Streams (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Total revenue $ 15,846 $ 14,925 $ 15,878
Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 12,979 12,766 13,829
Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 681 [1] 212 160
Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,615 1,519 1,390
Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 570 [2] 428 500
International Markets [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,958 1,903 2,032
International Markets [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,840 1,806 1,889
International Markets [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 24 [1] 19 13
International Markets [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 38 46 65
International Markets [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 56 [2] 33 65
Other activities [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 926 1,045 1,151
Other activities [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 565 671 739
Other activities [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 5 [1] 4 4
Other activities [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 0 0 0
Other activities [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 357 [2] 370 408
North America [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 8,124 7,452 7,809
North America [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 5,944 5,834 6,394
North America [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 601 [1] 139 92
North America [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 1,577 1,471 1,323
North America [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 2 [2] 8 (1)
Europe [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 4,837 4,525 4,886
Europe [Member] | Sale of Goods [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 4,631 4,455 4,807
Europe [Member] | Licensing Arrangements [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue 51 [1] 51 50
Europe [Member] | Distribution [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue   1 1
Europe [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Total revenue $ 155 [2] $ 18 $ 27
[1] Revenues from licensing arrangements in North America segment were mainly comprised of $500 million upfront payment received in connection with the collaboration on Teva’s anti-TL1A asset. See note 2.
[2] “Other” revenues in Europe segment mainly related to the sale of certain product rights.